Skip to content

Barry Ticho, Chief Medical Officer at Stoke Therapeutics, sold STOK on Jul 1, 2026

Data as of Oct 16

▼ SELL$219K6,728 shares at $32.62Barry Ticho Chief Medical OfficerSTOK Stoke Therapeutics, Inc.
Watch STOK
Traded
Jul 1, 2026
Disclosed
Jul 6, 2026
Filed
5 days after the trade · late

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Barry Ticho, Chief Medical Officer at Stoke Therapeutics, sold STOK on Jul 1, 2026TRADEDDISCLOSED
STOKSimilar stocks (XLV — its sector index fund), rebased to STOK's price on the disclosure day
STOK since disclosure
−25.5%
after the sale
Similar stocks (XLV) since disclosure
+9.1%
XLV — its sector index fund

Change in closing price from Jul 6, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLBarry Ticho Chief Medical OfficerSTOK Stoke Therapeutics, Inc.$16.6Kdisclosed Jul 6 · filed 5 days after the trade · late

See every trade on STOK →